"Designing Growth Strategies is in our DNA"
The global orthobiologics market size was USD 5,830.1 million in 2018 and is projected to reach US$D8,261.6 million by 2026, exhibiting a CAGR of 4.5% in the forecast period (2019-2026).
The economic burden due to orthopedic injuries and osteoarthritis is increasing at a significant rate. According to the Centers for Disease Control and Prevention (CDC), over 30 Mn people in the U.S. are affected by osteoarthritis, making it a major concern for healthcare providers. Orthobiologics have considerably impacted orthopedic surgeries. The concept which was earlier used for regenerative medicines, has now expanded its area of application to spinal fusion, dental, maxillofacial, cartilage repair, knee arthroscopies and many others. The increasing demand and rapid adoption of the newly introduced products such as Medtronic’s Infuse, a bone morphogenetic protein, etc., are primary reasons for the surge in orthobiologics industry.
Request a sample to learn more about this report.
High Demand for Viscosupplements to Bolster the Market
Viscosupplements are injections of hyaluronic acid, which are directly administered into the joints. Viscosupplements are extensively used in the treatment of knee osteoarthritis, which is one of the major problems among the geriatric population. High product costs, entries of the new manufacturers, and recent marketing approvals are the factors attributed to the expansion of viscosupplements. Furthermore, improving reimbursement guidelines for viscosupplements are also favoring the viscosupplements segments. Considering the aforementioned factors, the high demand for viscosupplements is anticipated to drive the global orthobiologics market growth during the forecast period.
To know how our report can help streamline your business, Speak to Analyst
Based on the product, the global market segments include viscosupplements, bone growth stimulators, demineralized bone matrix, synthetic bone substitutes, stem cells, allograft, and others. Belonging to the first generation of orthobiologics, viscosupplements dominated the market in 2018 with a share of 32.1% in the global market. Based on applications, the global market segments include spinal fusion, maxillofacial & dental, soft tissue repair, reconstructive & fracture surgery, and others. Spinal fusion accounted for the highest market orthobiologics Market share in 2018, owing to the increased use of synthetic matrices and allografts in spine fusion surgeries. Soft tissue repair segment witnessed the highest growth due to the increased cases of sports injuries and demand for orthobiologics for cartilage repair. Based on end user, the global market segments include hospitals, ambulatory surgical centers and specialty clinics.
Growing Trend of Orthopedic Surgery in Outpatient Settings to Favor the Market in North America
The market in North America was valued at US$ 2,326.2 Mn in 2018 and is estimated to dominate the market throughout the forecast period. Business strategies of leading manufacturers in the U.S., favorable reimbursement policies, increasing prevalence of degenerative bone diseases and growing trend of orthopedic surgeries in outpatient settings are the factors that may boost the market in North America during 2019-2026. In terms of revenues, Europe is projected to be the second dominant region with a significant share in the market owing to the new marketing approval for Cingal, a viscosupplements in Europe. Asia Pacific is expected to register the highest CAGR during the forecast period, which is attributable to the increasing demand for viscosupplements in India and rising number of standalone orthopedic clinics. Latin America and Middle East & Africa are expected to witness a considerable market potential in the forecast period owing to the rising demand for treatment of sports injuries and an increase in government initiatives for awareness of orthobiologics.
North America Orthobiologics Market, 2018
To get more information on the regional analysis of this market, Request a sample
Medtronic and Sanofi to Lead the Market
Medtronic has emerged as the leading player in the market, mainly due to the successful launch and rapid adoption for Infuse bone morphogenetic protein. Medtronic is estimated to hold the highest share in the forecast duration owing to the higher cost and strong sales force for Infuse and FDA approval received for the use of Infuse in new spine surgery indication in April 2018. Other players operating in the global market are DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Zimmer Biomet, Sea Spine, Bioventus, RTI Surgical Holdings, Inc., Musculoskeletal Transplant Foundation, Wright Medical Group N.V., and Anika Therapeutics, Inc.
The rising number of reconstructive and regenerative surgeries have resulted in increased demand for orthobiologic products. Orthobiologics are the products that are used during surgeries to aid quick healing of orthopedic injuries. These are made from products ranging from growth stimulators to synthetic bone substitutes.
The report provides qualitative and quantitative insights on the market. The market is segmented based on product type, application, end user, and geography. In terms of product type, the global orthobiologics market is segmented into viscosupplements, bone growth stimulators (Bone Morphogenetic Proteins and Platelet-Derived Growth Factors), demineralized bone matrix (DBM), synthetic bone substitutes, stem cells, allografts, and others. On the basis of application, the market is categorized into spinal fusion, maxillofacial & dental, soft tissue repair, reconstructive & fracture surgery, and others. The end users for orthobiologic products include hospitals, ambulatory surgical centres, and specialty clinics. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.
To gain extensive insights into the market, Request for Customization
Along with this, the orthobiologics market analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of soft tissue injuries for key countries, number of spinal fusion surgery for key countries, regulatory scenario in key countries, new product launch, key mergers and acquisitions: recent industry developments, and others.
By Product Type
By End User
Fortune Business Insights says that the orthobiologics market was valued at USD 5,830.1 Million in 2018 and is projected to reach USD 8,261.6 Million by 2026.
In 2018, the North America orthobiologics market was valued at USD 2,326.2 Million.
Growing at a CAGR of 4.5%, the market will exhibit significant growth in the forecast period (2019-2026)
The viscosupplements segment is expected to be the leading segment in this market during the forecast period.
Increasing applications of orthobiologics and rising demand for viscosupplements are the major factors driving the orthobiologics market.
Medtronic and Sanofi are the top players in the market.
North America is expected to hold the highest market share in the market.
The introduction of new products in the market and rising number of spinal fusion surgeries are the factors that are expected to drive the adoption of orthobiologics.
Increased research on Bone Morphogenetic Proteins (BMP) and use of stem cells and grafts for soft tissue repair are trends of the orthobiologics market
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry